Invention Grant
US08637262B2 Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof 失效
血管内皮生长因子C(VEGF-C)蛋白和基因,突变体及其用途

  • Patent Title: Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
  • Patent Title (中): 血管内皮生长因子C(VEGF-C)蛋白和基因,突变体及其用途
  • Application No.: US13646563
    Application Date: 2012-10-05
  • Publication No.: US08637262B2
    Publication Date: 2014-01-28
  • Inventor: Kari AlitaloVladimir Joukov
  • Applicant: Vegenics PTY Limited
  • Applicant Address: AU South Yarra
  • Assignee: Vegenics Pty Limited
  • Current Assignee: Vegenics Pty Limited
  • Current Assignee Address: AU South Yarra
  • Agent Jeanne M. Brashear
  • Main IPC: G01N33/53
  • IPC: G01N33/53 C07K16/00
Vascular endothelial growth factor C (VEGF-C) protein and gene, mutants thereof, and uses thereof
Abstract:
Provided are purified and isolated VEGF-C polypeptides capable of binding to at least one of KDR receptor tyrosine kinase (VEGFR-2) and Flt4 receptor tyrosine kinase (VEGFR-3); analogs of such peptides that have VEGF-C-like or VEGF-like biological activities or that are VEGF or VEGF-C inhibitors; polynucleotides encoding the polypeptides; vectors and host cells that embody the polynucleotides; pharmaceutical compositions and diagnostic reagents comprising the polypeptides; and methods of making and using the polypeptides. Methods of inhibiting endothelial cell proliferation are also provided.
Information query
Patent Agency Ranking
0/0